← USPTO Patent Applications

Multivalent Chlorotoxin Chimeric Antigen Receptors

Application US20260078529A1 Kind: A1 Mar 19, 2026

Inventors

Lei DING, Lawrence S. LAMB, JR.

Abstract

Described are γδ T-cells that express a multivalent CLTX-CAR and also express a survival factor, a population of the γδ T-cells that express a multivalent CLTX-CAR and the survival factor, pharmaceutical compositions thereof, and methods of treating cancer or a tumor in a subject comprising administering to a subject an effective amount of the multivalent CLTX-CAR γδ T-cells and co-administering a chemotherapeutic agent, e.g., the chemotherapeutic agent to which the survival factor confers resistance.

CPC Classifications

C40B 40/02 A61K 40/11 A61K 40/31 A61K 40/429 C07K 14/43522 C07K 14/70521 A61K 2239/47 C07K 2317/21 C07K 2317/24 C07K 2317/622

Filing Date

2025-04-09

Application No.

19174283